Long-term Risk of Recurrent Cervical Artery Dissection After Pregnancy (LONG-RECAP Study)
Status: Recruiting
Location: See all (12) locations...
Study Type: Observational
SUMMARY
Methods: Multicentric, observational case-control study based on pooled individual patient data from several stroke centers. Primary endpoint: Primary composite outcome measure includes the following outcomes: (i) occurrence of recurrent CeAD, (ii) occurrence of ischemic or hemorrhagic stroke, (iii) death.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• female
• prior symptomatic cervical artery dissection (= index CeAD)
• at least one long-term follow-up visit (at least 6 months after the initial event)
• with information available on outcome events:
• recurrent dissection
• ischemic stroke
• hemorrhagic stroke
• functional outcome assessed by mRS score
• with data on pregnancy after the initial event
• at least 18 years old at the initial event
Locations
United States
Utah
University of Utah
RECRUITING
Salt Lake City
Virginia
University of Virginia
RECRUITING
Charlottesville
Other Locations
Argentina
Stroke Unit Sanatorio Allende
RECRUITING
Córdoba
Austria
Department of Neurology, Medical University of Innsbruck
RECRUITING
Innsbruck
Finland
Helsinki University Central Hospital
RECRUITING
Helsinki
Germany
Charité Universitätsmedizin, Centrum für Schlaganfallforschung
RECRUITING
Berlin
Neurologische Klinik und Poliklinik, LMU Klinikum Campus Großhadern
RECRUITING
Munich
Israel
Hadassah-Hebrew University Medical Center
RECRUITING
Jerusalem
Italy
Neurology Clinic, University of Brescia
RECRUITING
Brescia
Mexico
Stroke Clinic, National Institute of Neurology and Neurosurgery Manuel Velasco Suárez
RECRUITING
Mexico City
Switzerland
University Hospital Basel, Stroke Center
RECRUITING
Basel
University Hospital Zurich, Stroke Center
RECRUITING
Zurich
Contact Information
Primary
Stefan T Engelter, MD
stefan.engelter@felixplatter.ch
+41 61 326 41 05
Backup
Sandro K Fischer
sandrokevin.fischer@usb.ch
+41 61 328 47 84
Time Frame
Start Date: 2023-01-01
Estimated Completion Date: 2025-07-01
Participants
Target number of participants: 1000
Treatments
Women with pregnancy after index CeAD
Women who became pregnant at least once after first index CeAD
Women without pregnancy after index CeAD
Women who did not became pregnant after first index CeAD
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Basel, Switzerland